Gene panel testing of 5589 <i><scp>BRCA</scp>1/2</i>‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian CancerJan Hauke, Eric Hahnen, Ellen Honisch et al.|Cancer Medicine|2018Cited by 168
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challengeSabine Grill, Anne S. Quante, Juliane Ramser et al.|Archives of Gynecology and Obstetrics|2020Cited by 8